Drug Index

EPOGEN/PROCRIT

Generic: EPOETIN ALFA

Review priority: STANDARD Marketing status: Prescription

Structured Monograph

Approval overview EPOGEN/PROCRIT is listed in Drugs@FDA under application 103234 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPOETIN ALFA Form and strength VIAL; SINGLE-USE - 10,000U/ML Sponsor AMGEN Submission history Latest submission status date: 2024-04-30 00:00:00. Submission type: SUPPL.